Composition Analysis of Lipid Nanoparticle Components with Agilent 1290 Infinity II ELSD

Application Note Biopharma Analysis of Lipid Nanoparticle Composition Author Sonja Schneider Agilent Technologies, Inc. 0 DLin-MC3-DMA DMG-PEG 2000 DSPC ×102 4.75 4.50 4.25 4.00 3.75 3.50 3.25 3.00 2.75 2.50 2.25 2.00 1.75 1.50 1.25 1.00 0.75 0.50 Cholesterol Response…

Application Note Biopharmaceuticals LC/MS Analysis of Lipid Composition in an mRNA LNP Formulation: A Stability Study Authors Li Zhang and Yi Yan Yang Bioprocessing Technology Institute Suresh Babu C.V. and Ravindra Gudhial Agilent Technologies, Inc. Abstract Lipid-based nanocarriers, known as…

Optimization of Universal Detection Methods for Lipid Nanoparticles 0.0 100.0 100.0 100.0 0.0 0.0 6 6 6 CAD Detection Power Function Value Evaporator Temp. Data Rate 1 40 °C 2 Hz SM-102 DSPC DSPE-PEG2000 Cholesterol DSPEPEG2000 Detection Cholesterol DSPC DSPEPEG2000…

Application note | 001928 Biopharma Characterization of lipid components in lipid nanoparticle (LNP) formulations Application benefits Authors Sissi White , Ken Cook , Sara Carillo , 1 2 3 • A simple UHPLC-CAD method was developed under enterprise compliance-ready Thermo…